Acknowledgement
None.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosure
B.M. received research funding from Sanofi, Pfizer, and BMS and provided consultancy/advisory services for Lilly, Servier, BMS, Amgen, and AstraZeneca; B.P.L.W. received research funding from BMS and provided consultancy/advisory services for BMS; all remaining authors declare that they have no conflicts of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
van der Zijden, C.J., van der Sluis, P.C., Mostert, B. et al. ASO Visual Abstract: Adjuvant Therapy for Patients with a Tumor-Positive Resection Margin After Neoadjuvant Chemoradiotherapy and Esophagectomy. Ann Surg Oncol (2024). https://doi.org/10.1245/s10434-024-15044-y
Published:
DOI: https://doi.org/10.1245/s10434-024-15044-y